A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: Safety and immunity

Vaccine

Volumn 29, Issue 3, 2011, Pages 444-450

  Lu, Chun Chi ^a   Wang, Yeau Ching ^b   Lai, Jenn Haung ^a   Lee, Tony Szu Hsien ^c   Lin, Hui Tsu ^b   Chang, Deh Ming ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

A H1N1 influenza vaccination; Systemic lupus erythematosus (SLE)

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; INFLUENZA VACCINE; PREDNISOLONE;

2009 H1N1 INFLUENZA; ADULT; ANTIBODY RESPONSE; ARTHRALGIA; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; FEVER; HEADACHE; HEMAGGLUTINATION; HUMAN; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA VACCINATION; MALAISE; MALE; MYALGIA; PAIN; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE DRUG DOSE; SWELLING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, VIRAL; AUTOANTIBODIES; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; VACCINES, SUBUNIT;

EID: 78650521741     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.081     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention (CDC) Swine influenza A (A/H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:400-402.
2. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(A/H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
3. Centers for Disease Control and Prevention (CDC) Outbreak of swine-origin influenza A (A/H1N1) virus infection-Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:467-470.
4. World Health Organization New influenza A (A/H1N1) virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec 2009, 84:249-257.
5. Kumar A., Zarychanski R., Pinto R., et al. Critically ill patients with 2009 influenza A(A/H1N1) infection in Canada. JAMA 2009, 302:1872-1879.
6. ANZIC Influenza Investigators, Webb S.A., Pettila V., et al. Critical care services and 2009 A/H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361:1925-1934.
7. Jain S., Kamimoto L., Bramley A.M., et al. Hospitalized patients with 2009 A/H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944.
8. Dawood F.S., Jain S., Finelli L., et al. Emergence of a novel swine-origin influenza A (A/H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
9. Centers for Disease Control and Prevention (CDC) Intensive-care patients with severe novel influenza A(A/H1N1) virus infection-Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009, 58:749-752.
10. Centers for Disease Control and Prevention (CDC) Use of influenza A (A/H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58:1-8.
11. Lu C.Y., Shao P.L., Chang L.Y., et al. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents. Vaccine 2010, 16(28):5864-5870.
12. Kung H.C., Huang K.C., Kao T.M., et al. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza. Vaccine 2010, 21(28):7337-7343.
13. Kao T.M., Hsieha S.M., Kung H.C., et al. Immune response of single dose vaccination against 2009 pandemic influenza A(H1N1) in the Taiwanese elderly. Vaccine 2010, 28:6159-6163.
14. Yurasov S., Wardemann H., Hammersen J., et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005, 201:703-711.
15. Mohan C., Datta S.K. Lupus: key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 1995, 77:209-220.
16. Pugh-Bernard A.E., Cambier J.C. B cell receptor signaling in human systemic lupus erythematosus. Curr Opin Rheumatol 2006, 18:451-455.
17. Wraith D.C., Goldman M., Lambert P.H. Vaccination and autoimmune disease: what is the evidence?. Lancet 2003, 362:1659-1666.
18. Mercado U., Acosta H., Avendaño L. Influenza vaccination of patients with systemic lupus erythematosus. Rev Invest Clin 2004, 56:14-18.
19. Brandt J.T., Triplett D.A., Alving B., et al. Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost 1995, 74:1185-1190.
20. Fattorossi A., Matricardi P.M., Pizzolo J.G., et al. Lack of specificity in the mechanisms involved in the enhancement of the concanavalin A driver human T lymphocyte stimulation by B-endorphin: studies on activation marker expression, cell cycle and interleukin release. J Biol Regul Homeost Agents 1991, 5:91-97.
21. Biselli R., Farrace S., D'Amelio R., et al. Influence of stress on lymphocyte subset distribution. A flow cytometric study in young student pilots. Aviat Space Environ Med 1993, 64:116-120.
22. Gladman D.D., Ibanez D., Urowitz B. Systemic lupus erythematosus disease activity index. J Rheumatol 2002, 29:288-291.
23. Fuenzalida L., Blanco S., Prat C., et al. Utility of the rapid antigen detection BinaxNOW A&B test for detection of novel influenza A (A/H1N1) virus. Clin Microbiol Infect 2009 Dec 29, [Epub ahead of print].
24. Belshe R.B., Newman F.K., Cannon J., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004, 351:2286-2294.
25. Choen A.D., Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 1996, 9:699-703.
26. Hess E.V., Hann H.B. Influenza immunization in lupus erythematosus: safe, effective?. Ann Intern Med 1978, 88:833-834.
27. Williams G.W., Steinberg A.D., Reinsen L. Influenza immunization in SLE. A double blind trial. Ann Intern Med 1978, 88:729-734.
28. Ristow S.C., Douglas R.G., Condemi J.J. Influenza vaccination of patients with SLE. Ann Intern Med 1978, 88:786-789.
29. Broadman R., Gilfillan R., Glass D. Influenza vaccine response in SLE. Ann Intern Med 1978, 88:735-740.
30. Louie J.S., Nies K.M., Shoji K.T., et al. Clinical and antibody responses after influenza immunization in SLE. Ann Intern Med 1978, 88:790-792.
31. Herron A., Dettleff G., Hixon B., et al. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA 1979, 242:53-56.
32. Holvast A., Huckriede A., Wilschut J., et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 2006, 65:913-918.
33. Rimmelzwaan G.F., Nieuwkoop N., Brandenburg A., et al. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. Vaccine 2000, 19:1180-1187.
34. Rimmelzwaan G.F., Nieuwkoop N., Brandenburg A., et al. Vaccination of the immunosuppressed adult patient with rheumatologic disease. Rheum Dis Clin North Am 1999, 25:567-584.
35. Holvast A., van Assen S., de Haan A., et al. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis Rheum 2009, 60:2438-2447.
36. Abu-Shakra M., Zalmanson S., Neumann L., et al. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol 2000, 27:1681-1685.
37. Abu-Shakra M., Press J., Sukenik S., et al. Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies. Clin Rheumatol 2002, 21:369-372.
38. Kanakoudi-Tsakalidou F., Trachana M., Pratsidou-Gertsi P., et al. Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin Exp Rheumatol 2001, 19:589-594.
39. Del Porto F., Laganà B., Biselli R., et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 2006, 24:3217-3223.
40. Tarján P., Sipka S., Lakos G., et al. Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 2006, 35:241-243.
41. Lapphra K., Huh L., Scheifele D.W. Adverse neurologic reactions after both doses of pandemic H1N1 influenza vaccine with optic neuritis and demyelination. Pediatr Infect Dis J 2010, [Epub ahead of print].
42. DeStefano F., Verstraeten T., Jackson L.A., et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003, 60:504-509.
43. Holvast B., Huckriede A., Kallenberg C.G., et al. Influenza vaccination in systemic lupus erythematosus. Autoimmun Rev 2007, 6:300-305.
44. Wie{ogonek}sik-Szewczyk E., Romanowska M., Mielnik P., et al. Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin Rheumatol 2010, 29:605-613.
45. Abu-Shakra M., Press J., Varsano N., et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 2002, 29:2555-2557.
46. Pyhala R., Kumpulainen V., Alanko S., et al. HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992. Vaccine 1994, 12:947-952.
47. Gross P.A., Sperber S.J., Donabedian A., et al. Paradoxical response to a novel influenza virus vaccine strain: the effect of prior immunization. Vaccine 1999, 17:2284-2289.
48. Govaert T.M., Sprenger M.J., Dinant G.J., et al. Immune response to influenza vaccination of elderly people: a randomized double-blind placebo-controlled trial. Vaccine 1994, 12:1185-1189.
49. De Bruijn I., Remarque E.J., Beyer W.E., et al. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine 1997, 15:1323-1329.
50. De Bruijn I., Remarque E.J., Jol-van der Zijde C.M., et al. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis 1999, 179:31-36.
51. Keitel W.A., Cate T.R., Couch R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988, 127:353-364.
52. Keitel W.A., Cate T.R., Couch R.B., et al. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five-year period. Vaccine 1997, 15:1114-1122.